Welcome to our dedicated page for Cronos Group news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group stock.
Cronos Group Inc. reports developments for a global cannabis and cannabinoid company focused on consumer goods, cannabis research, technology and product development. Its brand portfolio includes Spinach®, PEACE NATURALS®, LIT® and Lord Jones®, with news often centered on product innovation across Canadian cannabis formats such as pre-rolls and vapes.
Recurring Cronos updates also cover operating and financial results, earnings conference calls, annual shareholder meetings, proxy and governance matters, capital-structure disclosures and public-company presentations. The company’s disclosures connect brand launches and R&D-driven product development with the financial and governance reporting of a Nasdaq- and TSX-listed cannabis issuer.
Cronos Group (NASDAQ: CRON; TSX: CRON) reported results of its June 18, 2026 Annual Meeting of Shareholders. Holders of 271,828,759 shares, or 72.24% of outstanding common shares, were represented. All director nominees were elected, each receiving over 93.6% support.
Shareholders backed an advisory say-on-pay resolution with 99.09% support and chose annual future say-on-pay votes. They also approved Davidson & Company LLP as independent auditor for fiscal 2026 and authorized the Board to set auditor remuneration.
Cronos (NASDAQ: CRON, TSX: CRON) expanded its share repurchase flexibility by adding a TSX normal course issuer bid to its existing buyback program.
The company may repurchase up to US$50 million or 18,712,918 common shares (about 5.02% of shares) across U.S. and Canadian marketplaces through May 13, 2027.
Cronos (NASDAQ: CRON; TSX: CRON) announced that its Spinach® vape portfolio became the top-selling vape brand in Canada, holding a 10.4% market share in April 2026 and leading the category since January 2026.
New Spinach PUFFERZ™ flavors and the first limited-time Orange Vanilla Twist 1g vape will launch in Alberta and Ontario in late June, with wider Canadian availability later in summer.
Cronos Group (NASDAQ: CRON) reported Q1 2026 net revenue of $45.2 million, up 40% year-over-year, with gross profit of $19.2 million and net income of $15.7 million. Adjusted EBITDA rose to $5.1 million. Cash and cash equivalents totaled $821.9 million.
The Board authorized a new $50 million share repurchase program commencing May 14, 2026. Cronos highlighted record revenue in Israel and other international markets, leading Canadian vape and edibles share, and extended the outside date to close its planned CanAdelaar acquisition to September 9, 2026.
Cronos (NASDAQ: CRON) expanded distribution of Spinach STIX®, its first cylindrical-style pre-roll, to eight Canadian provinces on May 6, 2026. The launch targets growing consumer demand for cylindrical pre-rolls, which represented $17 million in March 2026 retail sales and the pre-roll category that accounts for 33%+ of national retail dollar sales.
Spinach STIX® ships in 10x0.4g formats across three strains with advertised THC levels of 24%–26%+ and is positioned as a portable, even-burning pre-roll option.
Cronos Group (NASDAQ: CRON; TSX: CRON) will hold its 2026 Annual Meeting of Shareholders in a virtual-only format on Thursday, June 18, 2026 at 11:00 a.m. ET. Registered shareholders and duly appointed proxyholders may participate, ask questions, and vote online.
The company’s proxy statement and participation instructions are available on the investor relations website. A replay will be posted in the investor relations events section about 24 hours after the meeting.
Cronos Group (NASDAQ: CRON) will hold its 2026 first quarter earnings conference call on Monday, May 11, 2026 at 8:30 a.m. ET. Senior management will discuss the Company’s financial results and answer investor questions after prepared remarks.
Participants should register online and are encouraged to dial in 15 minutes early; the webcast will be archived for replay on the company website.
Cronos Group (NASDAQ: CRON) announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 38th Annual ROTH Conference on Monday, March 23, 2026 at 11:30 AM PDT.
A live webcast will be available via the company’s Investors site at https://ir.thecronosgroup.com/events-presentations, allowing investors to watch the presentation in real time.
Cronos Group (NASDAQ: CRON) reported record net revenue of $44.5M in Q4 2025 and $146.6M for FY 2025, up 47% and 25% year-over-year respectively. Adjusted EBITDA improved to $10.1M for the year. The company holds approximately $832M in cash and short-term investments and announced a €57.5M (~$67M) agreement to acquire CanAdelaar, subject to Netherlands regulatory clearances expected in H1 2026.
Cronos (NASDAQ: CRON) launched Spinach PUFFERZ™, a 1g all‑in‑one vape infused with liquid diamonds and delivering 98.1% THC. The palm‑style device features a squishy exterior, dual ceramic coil, boost button and battery meter. Three flavors debut now in Alberta, British Columbia and Ontario; national availability by April 2026.
The product targets modern cannabis consumers seeking design, flavor and convenience under the Spinach brand.